|
Volumn 2, Issue 5, 2005, Pages 232-233
|
How does antiangiogenic therapy affect brain tumor response to radiation?
|
Author keywords
Antiangiogenic therapy; Brain glioma; Radiotherapy; Vascular endothelial growth factor; VEGFR
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANGIOPOIETIN RECEPTOR;
MATRIX METALLOPROTEINASE INHIBITOR;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY DC101;
RECEPTOR ANTIBODY;
UNCLASSIFIED DRUG;
VASCULOTROPIN RECEPTOR 2;
ANIMAL MODEL;
CANCER CHEMOTHERAPY;
CANCER INHIBITION;
CANCER RADIOTHERAPY;
DRUG MECHANISM;
GAMMA RADIATION;
GLIOMA;
HYPOXIA;
MOUSE;
NONHUMAN;
OXYGENATION;
PRIORITY JOURNAL;
RADIATION DOSE;
RADIATION RESPONSE;
RECEPTOR BLOCKING;
SHORT SURVEY;
TUMOR VASCULARIZATION;
ANGIOGENESIS INHIBITORS;
ANIMALS;
BRAIN NEOPLASMS;
CELL HYPOXIA;
COMBINED MODALITY THERAPY;
GAMMA RAYS;
GLIOMA;
MALE;
MICE;
MICE, NUDE;
RADIATION TOLERANCE;
|
EID: 20444491614
PISSN: 17434254
EISSN: None
Source Type: Journal
DOI: 10.1038/ncponc0177 Document Type: Short Survey |
Times cited : (9)
|
References (5)
|